GGrantIndex
Sort

51,570 grants matching autoimmune disease

Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults

$515,756
Michael R Knowles · Univ Of North Carolina Chapel Hill · U54 · FY2020 · HL

Discovery of small molecules inhibiting Toll-like receptor-mediated inflammation

$515,751
Hans Haecker · University Of Utah · R01 · FY2021 · AI

Pathogenic Autoantibodies with Specificity for Aberrant Glycoproteins: Assessment of a Therapeutic Target in an Autoimmune Disease

$515,750
Todd Jason Green · University Of Alabama At Birmingham · R01 · FY2022 · AI

Pathogenic Autoantibodies with Specificity for Aberrant Glycoproteins: Assessment of a Therapeutic Target in an Autoimmune Disease

$515,750
Todd Jason Green · University Of Alabama At Birmingham · R01 · FY2020 · AI

Pathogenic Autoantibodies with Specificity for Aberrant Glycoproteins: Assessment of a Therapeutic Target in an Autoimmune Disease

$515,750
Todd Jason Green · University Of Alabama At Birmingham · R01 · FY2024 · AI

Pathogenic Autoantibodies with Specificity for Aberrant Glycoproteins: Assessment of a Therapeutic Target in an Autoimmune Disease

$515,750
Todd Jason Green · University Of Alabama At Birmingham · R01 · FY2023 · AI

Pathogenic Autoantibodies with Specificity for Aberrant Glycoproteins: Assessment of a Therapeutic Target in an Autoimmune Disease

$515,750
Todd Jason Green · University Of Alabama At Birmingham · R01 · FY2021 · AI

Vanderbilt University: Clinical Center Application, Type 1 Diabetes TrialNet

$515,743
William E Russell · Vanderbilt University · U01 · FY2014 · DK

The contribution of GPCRs to thymocyte medullary entry and central tolerance

$515,711
Lauren Ilyse Richie Ehrlich · University Of Texas At Austin · R01 · FY2015 · AI

Translation of evolution-guided insights for new models of human infectious disease

$515,674
Patrick S Mitchell · University Of Washington · DP2 · FY2021 · AI

Molecular Mechanisms in Innate immunity

$515,673
Herbert Morse · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

North American Pancreatitis Study 2 (NAPS2)

$515,637
David C Whitcomb · University Of Pittsburgh At Pittsburgh · R01 · FY2006 · DK

Cytokine receptor populations in human autoimmune diabetes

$515,631
Nora E Sarvetnick · University Of Nebraska Medical Center · U01 · FY2012 · AI

Development of mAb therapeutics against biothreat and emerging diease agents

$515,568
Thomas Briese · Columbia University Health Sciences · U54 · FY2010 · AI

Complement and CR2/CD21 in the Immune Pathogenesis of HIT

$515,562
Gowthami M Arepally · Duke University · R01 · FY2019 · HL

PHASE I/II TRIAL OF HOKT3(1(ALA-ALA) IN TYPE 1 DIABETES

$515,514
Columbia University Health Sciences · R01 · FY2003 · DK

Defining the effector gene repertoire in systemic autoimmunity by ENU mutagenesis

$515,512
Dwight H Kono · Scripps Research Institute, The · R01 · FY2010 · AR

Elucidating how long 3'UTRs form and cause autoinflammation

$515,387
Hachung Chung · Columbia University Health Sciences · R01 · FY2025 · AI

Discovery of small molecules inhibiting Toll-like receptor-mediated inflammation

$515,252
Hans Haecker · University Of Utah · R01 · FY2020 · AI

Chromosome 1 Regions Linked to SLE in Multiplex Families

$515,250
Betty P. Tsao · University Of California Los Angeles · R01 · FY2006 · AR

Role of the CD47 Pathway in Rheumatoid Arthritis Pathogenesis and Treatment

$515,173
Benjamin Douglas Korman · University Of Rochester · R01 · FY2023 · AR

Mechanisms of non-IgE Mast Cell Activation by Environmental Particulates

$515,084
Jared Michael Brown · University Of Colorado Denver · R01 · FY2020 · ES

Mechanisms of Corneal Neuro-Immune Crosstalk

$515,045
Pedram Hamrah · Tufts Medical Center · R01 · FY2022 · EY

Prospective Study of Vitamin D and Multiple Sclerosis

$515,014
Alberto Ascherio · Harvard School Of Public Health · R01 · FY2008 · NS

WAVE Regulatory Complex in Primary Immunodeficiency Disease and autoimmunity

$514,941
Brian M Iritani · University Of Washington · R01 · FY2024 · AI